Text: HF2409            Text: HF2411
Complete Bill History


House File 2410

HOUSE FILE BY COMMITTEE ON COMMERCE (SUCCESSOR TO HSB 529) A BILL FOR 1 An Act relating to restrictions for drug product selection 2 relative to antiepileptic drugs. 3 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA: TLSB 5240HV (2) 83 pf/nh PAG LIN 1 1 Section 1. Section 155A.32, Code 2009, is amended by adding 1 2 the following new subsection: 1 3 NEW SUBSECTION. 2A. a. The pharmacist shall not exercise 1 4 the drug product selection described in this section for 1 5 an antiepileptic drug or formulation of an antiepileptic 1 6 drug, whether brand name or generic name, prescribed for the 1 7 treatment of epilepsy, prior to meeting all of the following 1 8 requirements: 1 9 (1) Providing notification to the patient or the patient's 1 10 representative. 1 11 (2) Providing notification to the authorized prescriber. 1 12 b. For the purposes of this subsection, "notification" 1 13 shall require the pharmacist to provide written or documented 1 14 verbal communication to the prescriber and patient or patient's 1 15 representative at the time the drug is dispensed. Notification 1 16 to the patient shall include informing the patient or patient's 1 17 representative of the patient's right to reject the drug being 1 18 dispensed. 1 19 c. If any part of the prescription under this subsection 1 20 will be paid by expenditure of public funds authorized under 1 21 chapter 249A, the rules, policies, and procedures applicable 1 22 to prescription drugs under that chapter shall apply to a 1 23 prescription under this subsection. 1 24 d. This subsection shall apply if the patient's condition is 1 25 being treated with a specific drug, strength, dosage form, and 1 26 dosing regimen from a specific manufacturer. 1 27 e. For the purposes of this subsection, drug product 1 28 selection includes dispensing the antiepileptic drug of 1 29 another manufacturer instead of the antiepileptic drug of the 1 30 manufacturer which the patient is currently prescribed, and 1 31 substituting a generic version for a brand version, a brand 1 32 version for a generic version, or a generic version for a 1 33 generic version of a different manufacturer. 1 34 EXPLANATION 1 35 This bill provides an exception to authorization of drug 2 1 product selection by pharmacists by prohibiting such drug 2 2 product selection for an antiepileptic drug or formulation 2 3 of an antiepileptic drug, whether brand name or generic 2 4 name, prescribed for the treatment of epilepsy, unless the 2 5 pharmacist first provides notification to the patient or the 2 6 patient's representative and to the authorized prescriber. The 2 7 bill specifies the requirements for providing notification, 2 8 under what conditions the bill applies, and what drug product 2 9 selection includes under the bill. The bill also provides that 2 10 if any part of the prescription will be paid by expenditure of 2 11 public funds authorized under Code chapter 249A (Medicaid), 2 12 the rules, policies, and procedures applicable to prescription 2 13 drugs under Code chapter 249A are to apply to the prescription.
Text: HF2409            Text: HF2411 Complete Bill History